'You are going overboard': Bombay HC imposes ₹5 lakh cost on FDA for not restoring Pune shop's licence
Maharashtra FDA Commissioner Tukaram Mundhe said he would examine the order before responding — “We go as per the law, as per the processes, we follow it, and we implement it”
The Bombay High Court has imposed a ₹5 lakh fine on the Maharashtra Food and Drug Administration (FDA) for suspending the licence of a Pune-based sweets shop despite a 98% compliance report, according to a ruling made on August 17, 2026. The court's decision came after the FDA's action was deemed "overboard" and "going overboard" by the court, which acknowledged that the regulator's intentions were commendable, but its approach was misguided.
The Bombay High Court's Bench, consisting of Acting Chief Justice Ravindra Ghuge and Justice Gautam Ankhad, expressed concern over the Food and Drug Administration's "strange policy and perverse" move. The court emphasized that the FDA's suspension of the sweets shop's licence, despite a high compliance rate, caused significant financial losses to the business.
The high court's ruling highlights the importance of balancing regulatory intent with practical consequences and avoiding measures that could harm businesses unfairly.
Written by urgent.news from The Hindu's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
